Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

被引：3

作者：

Abdallah, Mostafa ^{[1
]}

McCullough, Kristen ^{[1
]}

Ilyas, Rimal ^{[1
]}

Begna, Kebede H. ^{[1
]}

Al-Kali, Aref ^{[1
]}

Litzow, Mark R. ^{[1
]}

Hogan, William J. ^{[1
]}

Mangaonkar, Abhishek ^{[1
]}

Alkhateeb, Hassan ^{[1
]}

Shah, Mithun V. ^{[1
]}

Elliott, Michelle A. ^{[1
]}

Foran, James M. ^{[2
]}

Badar, Talha ^{[2
]}

Palmer, Jeanne M. ^{[3
]}

Yi, Cecilia Arana ^{[3
]}

Sproat, Lisa ^{[3
]}

Pardanani, Animesh ^{[1
]}

Patnaik, Mrinal M. ^{[1
]}

Olteanu, Horatiu ^{[4
]}

Ketterling, Rhett P. ^{[5
]}

Tefferi, Ayalew ^{[1
]}

Gangat, Naseema ^{[1
]}

机构：

[1] Mayo Clin, Div Hematol, Rochester, MN 55905 USA

[2] Mayo Clin, Div Hematol, Jacksonville, FL USA

[3] Mayo Clin, Div Hematol, Scottsdale, AZ USA

[4] Mayo Clin, Div Hematopathol, Rochester, MN USA

[5] Mayo Clin, Div Lab Med & Cytogenet, Rochester, MN USA

来源：

BLOOD CANCER JOURNAL | 2023年 / 13卷 / 01期

关键词：

D O I：

10.1038/s41408-023-00812-y

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：4

共 50 条

[1] Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Mostafa Abdallah
Kristen McCullough
Rimal Ilyas
Kebede H. Begna
Aref Al-Kali
Mark R. Litzow
William J. Hogan
Abhishek Mangaonkar
Hassan Alkhateeb
Mithun V. Shah
Michelle A. Elliott
James M. Foran
Talha Badar
Jeanne M. Palmer
Cecilia Arana Yi
Lisa Sproat
Animesh Pardanani
Mrinal M. Patnaik
Horatiu Olteanu
Rhett P. Ketterling
Ayalew Tefferi
Naseema Gangat
Blood Cancer Journal, 13
[2] Blastic, Plasmacytoid, Dendritic Cell Neoplasm (BPDCN)
Stranzenbach, R.
Roppa, M.
Stadler, R.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 : 21 - 21
[3] Blastic plasmacytoid dendritic cell neoplasm (BPDCN): the cutaneous sanctuary
Pileri, A.
Delfino, C.
Grandi, V.
Agostinelli, C.
Pileri, S. A.
Pimpinelli, N.
GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2012, 147 (06): : 603 - 608
[4] Blastic plasmacytoid dendritic cell neoplasm (BPDCN) - a diagnostic challenge
Cristian, M.
Seicaru, L.
Polimaru, R.
Baltatescu, G.
Calin, E.
Caloian, A.
Mazilu, L.
Deacu, S.
VIRCHOWS ARCHIV, 2024, 485 : S309 - S309
[5] Outcomes of CNS involvement in blastic plasmacytoid dendritic cell neoplasm (BPDCN).
Greenwell, Irl Brian
Davis, James
Li, Hong
Soong, Deborah
Taylor, Justin
Lane, Andrew A.
Rizzieri, David
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[6] Evaluating tagraxofusp for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN)
Wilson, Nathaniel R.
Pemmaraju, Naveen
EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (04) : 431 - 438
[7] Updates in Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Economides, Minas P.
Rizzieri, David
Pemmaraju, Naveen
CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2019, 14 (06) : 515 - 522
[8] Updates in Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Minas P. Economides
David Rizzieri
Naveen Pemmaraju
Current Hematologic Malignancy Reports, 2019, 14 : 515 - 522
[9] Role of tagraxofusp in treating blastic plasmacytoid dendritic cell neoplasm (BPDCN)
Alfayez, Mansour
Konopleva, Marina
Pemmaraju, Naveen
EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (02) : 115 - 123
[10] Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in an Elderly Female: A Rare Case
Al-Alwan, Ahmad
Khalid, Farhan
Vyas, Charmee
Sirpal, Vishakha
Bader, Husam
JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES, 2023, 13 (04):

← 1 2 3 4 5 →